Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 422.90
+1.65 (0.39%)
At close: Sep 25, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 42.41 billion as of September 25, 2026. Its market cap has increased by 15.03% in one year.
Market Cap
42.41B
Enterprise Value
45.84B
Revenue
9.81B
Ranking
n/a
PE Ratio
57.76
Stock Price
422.90
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 42.41B, an increase of 11,774.89%. That is a compound annual growth rate of 20.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 42.41B | 25.58% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 74.07B |
| Sanofi India | 72.43B |
| Morepen Laboratories | 63.92B |
| FDC Limited | 57.06B |
| Novartis India | 48.65B |
| Unichem Laboratories | 39.00B |
| Kwality Pharmaceuticals | 37.66B |
| Hikal | 28.70B |